Here's Why Here's Why Obesity Drugs Are Changing the Food We Buy
6 snips
May 23, 2025 Deirdre Hipwell, who leads Bloomberg's healthcare coverage in Europe, dives into the rising trend of weight loss drugs like Wegovy. She discusses how these medications are reshaping consumer eating habits, with a growing demand for high-protein, low-calorie foods. Food companies like Nestle and Danone are adjusting their strategies in response to this shift. Hipwell also explores the challenges the food industry faces from potential regulations on ultra-processed foods and the exciting future of obesity treatments, including the move from injections to pills.
AI Snips
Chapters
Transcript
Episode notes
Obesity Drugs Transform Food Market
- Obesity drugs like GLP-1s are transformative for users and have skyrocketed demand.
- Food companies notice changing habits and shift toward nutritional, low-calorie products.
GLP-1 Drugs Change Appetite and Taste
- GLP-1 drugs dramatically reduce appetite and change taste preferences.
- Side effects like nausea and slowed digestion contribute to decreased eating.
Food Industry Responds to Drug Impact
- Food companies detect reduced food demand due to GLP-1 drugs but also face inflation and tariffs.
- Some view it as an opportunity to develop products suited for people on these drugs.